Low-dose naltrexone (LDN) is a safe, inexpensive, yet underused drug that is extremely beneficial for patients with any condition marked by immune system dysfunction. Naltrexone has been used in 50 mg doses for decades to help patients recover from addiction to alcohol, heroin, and other opiate drugs. However, more than 20 years ago it was discovered that very small doses of this drug—3 to 4.5 mg—have profound effects on the immune system.
LDN works by boosting levels of endorphins, peptides produced in the brain and adrenal glands, that are best known for relieving pain and enhancing sense of well-being—they’re responsible for the “runner’s high” brought on by strenuous exercise. But these natural peptides are also powerful modulators of the immune system. When LDN is taken at bedtime, it attaches to opioid receptors and temporarily blocks endorphins from attaching. This signals the body to increase production of endorphins, which helps orchestrate the activity of stem cells, macrophages, natural killer cells, T and B cells, and other immune cells. As a result, LDN enhances the body’s ability to fight disease.
Although LDN is gaining increasing recognition as a highly effective therapy for conditions ranging from autoimmune disorders and allergies to cancer and autism, it is largely ignored by conventional physicians. This is unfortunate, because our patients who have used this therapy, along with the other innovative treatments at the Whitaker Wellness Institute, have reaped profound benefits.
Patients with multiple sclerosis, rheumatoid arthritis, lupus, Crohn’s disease and other autoimmune disorders have seen reductions in flare-ups and intensity of symptoms. Those suffering with fibromyalgia and chronic fatigue report more energy and less pain. Individuals dealing with various types of cancer receive an invaluable immune boost from LDN. Children with autism have also been helped. Furthermore, because of its broad immune-enhancing properties, LDN is an excellent preventive therapy that boosts immune function in older individuals.
LDN is safe, effective, and inexpensive. The only problem most patients encounter is finding a physician who knows about it and is willing to prescribe it. The physicians at Whitaker Wellness have first-hand experience with this remarkable drug, and they use LDN along with our other innovative therapies to help patients get off their prescription drugs and regain their health and vitality.
Several diverse conditions benefit from treatment with low-dose naltrexone. They include:
- ALS (Lou Gehrig’s disease)
- Alzheimer’s disease
- Ankylosing spondylitis
- Celiac disease
- Chronic fatigue syndrome
- Crohn’s disease
- Emphysema (COPD)
- Inflammatory bowel disease
- Multiple sclerosis (MS)
- Parkinson’s disease
- Rheumatoid arthritis
- Ulcerative colitis
Click the links below to read about how we treated other people just like you with low-dose naltrexone at the Whitaker Wellness Institute and helped them get back on the road to health.
One-Stop Shop for Wellness
Renowned physician, author, and speaker, Julian Whitaker, MD, opened the doors of the Whitaker Wellness Institute in 1979. Since then, our clinic has helped more than 45,000 patients overcome serious health challenges and get back on the road to healthy living. We’re proud to offer nearly two dozen safe, innovative, healing therapies under one roof—that’s more than any other facility in the northern hemisphere. Just think of us as your “one-stop shop for wellness.”
To get started and find out how receiving low-dose naltrexone at the Whitaker Wellness Institute can alleviate a variety of health conditions from autoimmune disorders and allergies to cancer and autism and help restore your health and vitality, click on the buttons below to schedule a complimentary consultation or contact us to learn more. You can also schedule your complimentary consultation or obtain more information by calling our Patient Services Representatives at (800) 488-1500.
Please share our low-dose naltrexone page with your friends and family on your favorite social media site(s) below: